Alternatives to Cue Biopharma, .

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Biopharmaceutical company focused on developing and commercializing innovative medicines.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotechnology company developing novel immunotherapies for cancer.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Developing novel therapeutics for cancer by targeting the tumor microenvironment.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Develops and manufactures biologics for therapeutic applications.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

AI-powered spatial biology platform for precision medicine and drug development.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

AI-powered platform for antibody discovery and development to create new medicines.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Immunotherapy company targeting oncology and autoimmune diseases.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Clinical-stage immunotherapy company developing novel treatments for cancer.

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

Developing a new histotripsy therapeutic platform for cancer treatment.

South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.